Meet the Team - KMC Healthcare

OUR TEAM

Kelly Makarounas-Kirchmann

Founder & Principal, KMC Health Care | Leading Health Economist & Strategic Advisor

Kelly is one of Australia’s most experienced Health Economists, with over 30 years of impact in the pharmaceutical and MedTech sectors. A recognised expert in market access and health technology assessment (HTA), she combines technical depth with strategic insight to support successful reimbursement outcomes.

Her career spans industry, academia, and government advisory, giving her a comprehensive view of the healthcare landscape. She has led numerous PBAC, MSAC, and PLAC submissions, developed pricing and risk-sharing strategies, and worked across a wide range of therapeutic areas.

Kelly currently lectures in Health Economics at Monash University and chairs the board of a biotech start-up. She is known for her collaborative, solutions-focused approach and commitment to patient-centred outcomes.

Expertise:
Reimbursement strategy | HTA submissions | Economic modelling
Pricing & risk-sharing | Policy reform | Stakeholder engagement

Matt Kirchmann

Principal, KMC Health Care | Health Economist & Legal Strategist

Matt Kirchmann is a solicitor and economist with over 25 years of experience in health economics, reimbursement strategy, and market access. As a co-founder of KMC Health Care, he helps pharmaceutical and MedTech companies navigate Australia’s complex reimbursement landscape.

Matt has led successful PBS and MSAC submissions, pricing negotiations, and financial modelling for a wide range of therapies and technologies. His rare combination of legal and economic expertise allows him to deliver cost-effective, compliant, and strategically positioned solutions.

Known for his clarity and precision, Matt is a skilled communicator who simplifies complex regulatory and economic issues—supporting clients with policy engagement, submission drafting, and stakeholder alignment.

Expertise:
Economic & financial modelling | PBS/MSAC submissions
Pricing negotiations | Market viability analysis
Policy drafting | Strategic access planning

Matt holds Economics and Law degrees from Monash University and previously lectured in economics. He brings pragmatic, data-driven insight and end-to-end support to every engagement.

Carolyn Rutherford

Health Economist | Market Access Specialist

Carolyn is a seasoned health economist and pharmacist with over 25 years of experience in the pharmaceutical industry. She brings a unique blend of clinical knowledge and commercial insight to market access and health economics strategy.

Her career includes leadership roles at CSL and GSK, where she led teams in securing PBS listings, pricing strategies, and cross-functional product development. Carolyn has worked across a wide range of therapeutic areas, including pain, infectious diseases, diabetes, respiratory, HIV, dermatology, and medical devices.

With deep expertise in the Pharmaceutical Benefits Scheme (PBS), she has successfully delivered PBAC submissions, hospital formulary applications, and pricing dossiers. Her background in both hospital and retail pharmacy informs her practical, patient-focused approach.

Now at KMC Health Care, Carolyn provides tailored, strategic support to help clients achieve reimbursement success in a complex regulatory environment.

Expertise:
Market access strategy | PBAC submissions | Pricing & reimbursement
Hospital formulary applications | Cross-functional leadership | Policy insight

Diana Lau

Medical Affairs | Medical Writing | Market Access
Director at PharmaVerse | Writer at KMC Health Care

Dr. Diana Lau is a Medical Affairs expert with over 15 years of experience across the pharmaceutical and healthcare sectors. She is the Director of PharmaVerse Medical Communications and Consulting Services and serves as a Health Economics Medical Writer for KMC Health Care.

Diana holds a PhD in Medicine from the University of New South Wales, where her research on neuroblastoma earned the Dean’s List Award. She has held leadership roles at Teva Pharmaceuticals and Novartis, contributing to product launches, PBS submissions, and successful reimbursement strategies.

Known for her ability to translate complex science into clear, impactful messaging, Diana specialises in demonstrating the value of medicines to payors, healthcare professionals, and other stakeholders. Her work has supported label expansions and improved patient access across multiple therapeutic areas.

Expertise:
Medical Affairs strategy | PBS submissions | Medical writing
Market access support | Product launches | Scientific communication

José Ignacio Sedeño

Strategy & Financial Analyst | Health Economics & Market Access | Bilingual (EN/ES)

José Ignacio brings over 8 years of experience across healthcare, government, and industry, combining financial expertise with strategic insight to support data-driven decisions in health economics and market access.

He has worked with leading organisations including Roche, CitiBank, and Mexico’s Department of Economic Development, delivering pricing strategies, investment evaluations, and operational improvements. His skill set spans financial modelling, KPI analysis, risk assessment, and stakeholder engagement—helping turn complex data into actionable outcomes.

Now based in Melbourne, José supports clients with pricing, reimbursement, and economic evaluations across the healthcare sector. Known for his clarity and precision, he works seamlessly across multidisciplinary teams to deliver structured, impactful results.

Expertise:
Strategic financial analysis | Market access strategy
Budget forecasting | KPI & risk analysis
Bilingual (English/Spanish) | Tools: SAP, Xero, Bloomberg Terminal

José holds an MBA and Finance Diploma from RMIT, a Bachelor in International Business from Universidad Iberoamericana, and a Corporate Finance Certificate from ITAM.

Sofia Georgiou

Strategic Advisor | Governance & Finance Expert | Community-Focused Leader

Sofia Georgiou is a strategic advisor with over 20 years of experience in governance, finance, and stakeholder engagement across education, finance, and not-for-profit sectors. She brings sharp insight into risk, compliance, and policy—delivering balanced, impactful outcomes in complex environments.

Her leadership spans board and committee roles, executive sales, and oversight of major public initiatives. Sofia has led multi-million-dollar infrastructure projects, steered budgets through crises like COVID-19, and mentored emerging leaders across sectors. Her professional background includes roles with Standard & Poor’s, GE Fleet Services, and leading consumer brands.

In the health economics space, Sofia contributes strategic oversight and stakeholder alignment to support access, equity, and sustainable outcomes.

Expertise:
Governance & financial oversight | Risk & compliance
Policy development | Stakeholder engagement
Community leadership | Consumer insight

Sofia holds a Bachelor of Economics (Hons) from Monash University and a Diploma in Treasury Management, and is an active member of Women on Boards and the Doncare Consumer Advisory Board.

WHO WE ARE

As a team of highly skilled consultants to the health care sector we specialize in the provision and reimbursement of pharmaceuticals in Australia, New Zealand, Asia and Europe.

Since 2000, we have been advising the pharmaceutical sector from the largest multi-national manufacturers and suppliers to wholesalers and community pharmacy as well as their representative organizations.

Our team’s breadth of skills and knowledge has come from many years of working in the healthcare industry.